REDUCEDStale
Novabridge Biosciences · NASDAQ
−107,978 sh · $79.9K
Filed 11 Sept 2026SEC Form 4view source
- ACQUIREDStale
Novabridge Biosciences · NASDAQ
+104,236 sh
Filed 8 Sept 2026SEC Form 4view source - ACQUIREDStale
Novabridge Biosciences · NASDAQ
+235,136 sh
Filed 8 Sept 2026SEC Form 4view source